FDA Inspection 1306352 — Howard J. Rubenstein, MD

Howard J. Rubenstein, MD — FEI 3014666772

The FDA completed an inspection of Howard J. Rubenstein, MD on Mar 5, 2026 in Saraland, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Mar 5, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Saraland, AL (United States)

Additional Details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.